MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with L

Lisinopril + Hydrochlorothiazide

Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets

Use with caution

Stability notes for Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets

Moisture sensitive medicine. Store in airtight (sealed) MCA.  Light sensitive medicine. Store in light resistant container.    No stability data in MCAs available.

Provenance

This recommendation is based on the products Zestoretic 10 tablets (Atnahs Pharma UK Ltd) and lisinopril/hydrochlorothiazide 10mg/12.5mg tablets (TEVA UK Limited).

Suppliers (12) of Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets
Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets (A A H Pharmaceuticals Ltd)
Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets (Alliance Healthcare (Distribution) Ltd)
Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets (Almus Pharmaceuticals Ltd)
Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets (Crescent Pharma Ltd)
Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets (Medihealth (Northern) Ltd)
Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets (Phoenix Healthcare Distribution Ltd)
Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets (Sigma Pharmaceuticals Plc)
Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets (Teva UK Ltd)
Lisoretic 10mg/12.5mg tablets (Bristol Laboratories Ltd)
Zestoretic 10 tablets (Atnahs Pharma UK Ltd)
Zestoretic 10 tablets (CST Pharma Ltd)
Zestoretic 10 tablets (Sigma Pharmaceuticals Plc)

Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets

Use with caution

Stability notes for Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets

Moisture sensitive medicine. Store in airtight (sealed) MCA.  Light sensitive medicine. Store in light resistant container.    No stability data in MCAs available.

Provenance

This recommendation is based on the products Zestoretic 20 tablets (Atnahs Pharma UK Ltd) and lisinopril/hydrochlorothiazide 20mg/12.5mg tablets (TEVA UK Limited).

Suppliers (10) of Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets
Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets (A A H Pharmaceuticals Ltd)
Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets (Alliance Healthcare (Distribution) Ltd)
Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets (Almus Pharmaceuticals Ltd)
Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets (Crescent Pharma Ltd)
Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets (Medihealth (Northern) Ltd)
Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets (Phoenix Healthcare Distribution Ltd)
Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets (Teva UK Ltd)
Lisoretic 20mg/12.5mg tablets (Bristol Laboratories Ltd)
Zestoretic 20 tablets (Atnahs Pharma UK Ltd)
Zestoretic 20 tablets (CST Pharma Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.